Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
AntidiabeticsSOLUTIONStandard

AWIQLI FLEXTOUCH

INSULIN ICODEC

Standard Dose
Refer to approved labeling
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AWIQLI FLEXTOUCH is listed in Drugs@FDA under application 761326 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN ICODEC Form and strength INJECTION;SOLUTION Sponsor NOVO NORDISK INC Submission history Latest submission status date: 2026-03-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview AWIQLI FLEXTOUCH is listed in Drugs@FDA under application 761326 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN ICODEC Form and strength INJECTION;SOLUTION Sponsor NOVO NORDISK INC Submission history Latest submission status date: 2026-03-26 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.